Main > > >BIOMARKER. *

Cardio.>BioMarker. Homocysteine. Blood Assay.
CE-Marked & FDA 510(k)-Cleared.
(*) Company; Patents & Web-Site Availa-
ble on Request.
UpDate: 2019. 03.18.




Onco.>BioMarker. Discovery. Reverse Proteomic Platform. (I)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 05.12.




Onco.>HepatoCellular Carcinoma (HCC). TREAT.: RamuciruMAb Injection.
1st Line Treat. with Sorafenib.
2nd Line Treat. with RamuciruMAb.
Advanced or Metastatic Cancer.
Biomarker-Driven Therapy>Alpha-FetoPro>
>tein (AFP) of ≥400 ng/mL.
Mechanism: VEGFR2 Inhibition.
"Primary" Cancer.
USA Approval Date: 2019. 05.13.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 11.29.





>BIOMARKER. *'s products
This section has no products